Inhalation anesthetics are used to induce and maintain general anesthesia while performing surgical procedures. Inhalation anesthetic agents are administered through masks or tracheal tubes. These agents get perfused into blood though alveoli and transported to central nervous system where these induce anesthesia.
Inhalation anesthesia has an advantage over other intravenous agents and is considered safer by surgeons. Rising adoption of these drugs in major markets such as U.S., Europe, and Japan is expected to drive revenue growth.

Market Analysis and Insights: Global Inhalation Anesthesia Market
In 2020, the global Inhalation Anesthesia market size was US$ 1128.8 million and it is expected to reach US$ 1397.5 million by the end of 2027, with a CAGR of 3.1% between 2021 and 2027
Global Inhalation Anesthesia Scope and Market Size
The global Inhalation Anesthesia market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Inhalation Anesthesia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Sevoflurane
Desflurane
Isoflurane

Segment by Application
Induction
Maintenance

By Company
AbbVie Inc.
Baxter
Piramal Enterprises Limited
Halocarbon Products Corporation
Hikma Pharmaceuticals PLC
Lunan Pharmaceutical Group Co.Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi Ag

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE